Using homologous recombination in embryonic stem cells (ESCs) carrying a drug-inducible reverse tetracycline transactivator (M2rtTA; hereafter abbreviated as rtTA) in the Rosa26 locus (ROSA)26Sor tm1(rtTA*M2) (ref. 10 ), we inserted a single polycistronic expression cassette termed 4F2A, which contains four mouse reprogramming genes (Oct4, Sox2, Klf4 and Myc (also known as c-Myc)) separated by three sequences encoding 2A selfcleaving peptides (Fig. 1a,b and Supplementary Fig. 1 ). This cassette has been shown to reprogram embryonic and adult mouse fibroblasts as well as human keratinocytes 12 . We generated transgenic mice carrying one copy of each transgene rtTA (1) :4F2A (1) (1:1) and intercrossed them to derive mice carrying various combinations of transgenes (rtTA (2) : 4F2A (1) , rtTA (1) :4F2A (2) and rtTA (2) :4F2A (2) ). We detected no tumors or other health problems in any of the transgenic mice up to 31 weeks of age (Supplementary Table 1) .
Using quantitative reverse-transcriptase PCR (qRT-PCR) analysis, we observed >100-fold induction of the 4F2A transgene in mouse embryonic fibroblasts (MEFs) carrying a single copy of both rtTA and 4F2A upon treatment with doxycyline ( Supplementary Fig. 2a) . We confirmed protein expression of three of the four factors by immunofluorescence, demonstrating robust doxycyline-inducible expression (Supplementary Fig. 2b ). The expression of Oct4 and Sox2 in doxycyline-treated MEFs was in the same range as that in ESCs, whereas Klf4 and c-Myc expression was three-to fivefold higher (Supplementary Fig. 3a) . To test whether factor expression was copy number-dependent, we quantified transcript levels in adult fibroblasts carrying different numbers of copies of the two transgenes. qRT-PCR analysis showed a copy number-and doxycyline-dependent expression of the 4F2A transgene (1:1 < 1:2 < 2:2; Supplementary Fig. 3b ).
We tested all mice carrying all combinations of transgene copy number for the ability to generate iPSCs from different tissues (Supplementary Table 2 ). MEFs isolated from mice carrying a single copy of each transgene (1:1) and grown in the presence of doxycyline gave rise within 2-4 weeks to colonies that could be picked. After 2-3 passages, several colonies yielded iPSC lines that expressed the pluripotency markers alkaline phosphatase (AP) and SSEA1 and had reactivated the endogenous Nanog locus as detected by immunostaining ( Supplementary Fig. 4 ). However, we did not obtain iPSCs from any tissue of adult mice carrying single copies of each transgene.
We assessed whether higher transgene expression levels would allow the generation of iPSCs from other cell types. We isolated iPSCs from adult liver cells and keratinocytes from mice carrying 2 copies of rtTA and 1 copy of 4F2A (2:1). Colonies appeared on days 12-16 after doxycyline addition (Supplementary Fig. 4a We report transgenic mouse models in which three or four reprogramming factors are expressed from a single genomic locus using a drug-inducible transgene. multiple somatic cell types can be directly reprogrammed to generate induced pluripotent stem cells (iPscs) by culture in doxycycline. because reprogramming factors are carried on a single polycistronic construct, the mice can be easily maintained, and the transgene can be easily transferred into other genetic backgrounds.
Generation of induced pluripotent stem cells (iPSCs) by primary infection using viral gene delivery has an efficiency of 0.001-0.1% [1] [2] [3] [4] . 'Secondary' systems use transgenic doxycylineinducible lentiviruses carrying the reprogramming factors to generate iPSCs from mouse somatic cells. This increases efficiency and also allows the reprogramming of genetically homogenous somatic cell populations while avoiding the genetic heterogeneity of primary infections [5] [6] [7] [8] . However, secondary mouse lines contain multiple (>7) proviruses, each with different capacities for reactivation, as indicated by the variegated expression of reprogramming factors after doxycyline exposure; additionally, factors cannot reactivate in some somatic tissues 6 . Although secondary models have been used to generate transgenic mice carrying all or a subset of reprogramming factors, it remains difficult to maintain all factors in one mouse because the multiple transgenes segregate in each generation 9 .
Here we report a transgenic mouse model that overcomes these limitations by inducing reprogramming factor expression from a single genomic site. The collagen type I (Col1a1) gene has previously been used as an expression locus for Pou5f1 (also known as Oct4) and induces transgene expression in multiple somatic cell types including mouse fibroblasts, keratinocytes, adrenal glands and neural precursor cells 6, 10, 11 . We generated 'single-gene' transgenic mouse strains that express three or four reprogramming factors from the Col1a1 locus. and we expanded them by manual passaging in doxycyclinecontaining medium until we observed ESC-like cells. Upon further culture in ESC medium without doxycycline, these lines were stable and expressed the pluripotency markers AP, SSEA1 and Nanog (Fig. 1c) . In contrast, CD11b + macrophages from spleen, CD19 + pro-B cells from bone marrow, intestinal epithelium, adult tail-tip fibroblasts and mesenchymal stem cells yielded iPSCs only in the presence of a second copy of 4F2A transgene. iPSCs from adult fibroblasts, CD11b + macrophages and pro-B cells were derived from mice carrying 2 copies of the 4F2A transgene and one copy of the rtTA transgene (2:1), whereas intestinal epithelial cells and mesenchymal stem cells required the presence of a second rtTA transgene (2:2). All iPSCs grew without doxycyline and expressed the pluripotency markers AP, SSEA1 and Nanog ( Fig. 1c and Supplementary  Fig. 4b ). We observed complete demethylation of the endogenous Oct4 promoter in five iPSC lines tested after bisulfite treatment and sequencing ( Fig. 1d and Supplementary Fig. 4c) .
To assess pluripotency, we tested the ability of Col1a1 4F2A iPSCs to differentiate in vivo. We injected liver, keratinocyte and MEF-derived iPSCs subcutaneously into severe combined immunodeficient (SCID) mice, giving rise to teratomas containing cells from all three germ layers ( Fig. 1e and Supplementary Fig. 4d ). We tested two lines for their ability to contribute to post-natal chimeras. MEF-derived iPSC line 11 contributed to adult chimeras after injection into blastocysts (Fig. 1f) . In addition, we generated high-contribution post-natal chimeras from macrophage-derived iPSC line 5, which transmitted the iPSC genome through the germline ( Fig. 1f and Supplementary Fig. 4e ).
Our data demonstrate that iPSCs can be derived from multiple somatic tissues of adult mice carrying the Col1a1 4F2A polycistronic transgene. The observation that some donor cell types, such as intestinal epithelial cells, mesenchymal stem cells, pro-B cells or tail-tip fibroblasts, yielded iPSCs only from mice with two copies of the transgene suggests that these cell types require higher amounts of factor expression for reprogramming than other cell types, such as MEFs or hepatocytes. Alternatively, there may be differences in the induction of the Col1a1 locus in different cell types, requiring multiple transgene copies to reach a threshold of reprogramming factor expression in some cases.
We characterized reprogramming efficiencies in CD19 + pro-B cells derived from mice with two transgene ratios, 1:2 and 2:2. Alkaline phosphatase-and Nanog-positive colonies appeared from cells of both genotypes around days 12-14 but with a 100-fold higher efficiency for the 2:2 than the 1:2 transgene ratio ( Supplementary Fig. 5a,b) . We then tested the kinetics of reprogramming CD19 + pro-B cells (using cells with transgene ratio 2:2) by performing doxycyline-withdrawal experiments and quantified doxycyline-independent, Nanog-positive iPSC colonies on day 25 after defined incubations in doxycyline-containing medium. We found that the number of Nanog-positive colonies increased with prolonged culture with doxycyline and directly correlated with the number of input donor cells ( Supplementary Fig. 5c,d ).
We established an additional transgenic model carrying only a subset of reprogramming factors, which could be used to identify replacements for Sox2 (ref. 9). Transduction with a lentivirus carrying a three-factor 2A expression cassette lacking Sox2 (Oct4-T2A-Klf4-E2A-cMyc; abbreviated as 3F2A) resulted in expression of all three reprogramming factors (Fig. 2a) . We then targeted this cDNA to the Col1a1 locus to generate Col1a1 3F2A transgenic ESCs that also contained a drug-inducible rtTA at the Rosa26 locus (Fig. 2b) . After injection of 3F2A ESCs into blastocysts, we obtained embryonic day (E)13.5 chimeric embryos and isolated MEFs. Expression of the transgene was induced ~120-fold by doxycyline treatment, as quantified by qRT-PCR ( Supplementary  Fig. 6a ). Additional infection with a lentivirus carrying Sox2 (pFUW-tetO Sox2) (Fig. 2c) allowed derivation of iPSCs staining positive for pluripotency markers AP, SSEA1 and Nanog (Fig. 2d) . Four independent iPSC lines (MEF 3F2A+S iPSC) carried a single Sox2 provirus (Fig. 2e) , in addition to the single copy of the rtTA and 3F2A transgenes ( Supplementary  Fig. 6b,c) . iPSC line 34 gave rise to high-contribution chimeras when injected into blastocysts (Fig. 2f and Supplementary  Table 3 ) with two of the four chimeras transmitting the iPSC genome through the germline (Fig. 2f) . Somatic cells derived from mice carrying the 3F2A transgene will be useful to screen for small molecules that can replace Sox2 for reprogramming. Recently, several strategies have been described that allow the generation of vector-free iPSCs by excision of the reprogramming transgenes [13] [14] [15] [16] . To establish a system that would permit the isolation of vector-free iPSCs from our defined transgenic strain, we created a Col1a1 4F2A targeting vector containing loxP sites flanking the transgene (Col1a1 2lox 4F2A) (Fig. 3a) , which would leave a single loxP site in the Col1a1 3′ untranslated region after Cre recombinase-mediated excision. We targeted the construct to the Col1a1 locus in ESCs carrying the rtTA transgene at the Rosa26 locus (Fig. 3b) . To assess whether the transgene could be excised, we exposed freshly passaged transgenic ESCs to a recombinant cell-permeable Cre protein (HTN-Cre) for 20 h. We assessed deletion of the transgene by scoring neomycin sensitivity in sibling colonies that we grew in the presence or absence of G418. We observed 2 out of 16 neomycin-sensitive colonies (Fig. 3c) that had deleted the transgene, as verified by Southern blot analysis (Fig. 3d) . Mice derived from this ESC line will be useful as donors for generating iPSCs that carry no vector sequences.
The transgenic models described here have several advantages over previous systems: (i) the previous 'secondary' iPSCs had been obtained by reprogramming cells from mice derived from primary iPSCs that had been initially generated by lentivirus-mediated gene transfer of the four reprogramming factors 6, 9 . Because the individual proviruses carrying the four factors segregate independently, it has been difficult to derive mice homozygous for all factors that could be used as a convenient source for reprogrammable cells. In the present system, all reprogramming factors are expressed from one cassette inserted into a single locus, facilitating the maintenance of the strain as well as the transfer of the reprogramming factors to mouse strains carrying other genetic determinants of interest. (ii) Unlike proviral transgenes that may be silenced by DNA methylation or other epigenetic mechanisms upon germline transmission, this transgenic system expresses the four reprogramming factors from a specific locus (Col1a1) that is widely expressed in the adult mouse and is capable of reprogramming cells from at least seven different tissues of the adult. (iii) We observed no tumors or other adverse effects in the transgenic mice suggesting that the Col1a1 4F2A system can be both safe and practical for extended breeding. (iv) Reprogramming factor stochiometries are fixed within each somatic cell type, facilitating comparison among iPSCs derived from multiple somatic tissues. Moreover, this system generates iPSCs that can now be compared to genetically identical ESCs. The above-described benefits of the single-gene transgenic system will also apply to the 3F2A strain that we report here, which will allow screening of somatic cells for small molecules to replace Sox2, and to mice generated from ESCs bearing the loxP-flanked construct, which will allow excision of the transgene for studies in vector-free iPSCs. (i) To generate Col1a1 4F2A, a ~5.8-kb EcoRI generated fragment containing Oct4-P2A-Sox2-T2A-Klf4-E2A-c-Myc (also named 4F2A) cDNA was generated from a previously published plasmid pFUW-Ubi-4F2A 12 and ligated into ptet.splicePL3 vector (containing tetO promoter and SV40 intron, pA) similarly digested with EcoRI to obtain ptet.splicePL3-OSKMpA. A 7.3-kb NotI-generated fragment was obtained from the ptet.splicePL3-OSKMpA and ligated into a NotI-digested mCol.loxneo targeting vector that contained both 5′ and 3′ homology arms toward the 3′ untranslated region of the Col1a1 locus as well as a pgkdriven neo resistance cassette for selection of transgenic cells. The resulting ~18 kb targeting construct (Col1a1 4F2A) was linearized with PvuI restriction enzyme digestion (25 µg), precipitated and resuspended in 400 µl of HEPES, then electroporated into V19 ESCs (V6.5 ESCs containing a reverse tetracycline trans-activator (M2rtTA) driven by the Rosa26 promoter). After 24 h, G418 (350 µg per ml) was added to ESC medium (DMEM supplemented with 10% FBS (Hyclone), leukemia inhibitory factor, β-mercaptoethanol (Sigma-Aldrich), penicillin-streptomycin, l-glutamine and nonessential amino acids (Invitrogen). Neo-resistant colonies were picked 10 d later, expanded and DNA was isolated for testing of correct targeting by Southen blot analysis. (ii) To generate Col1a1 2lox 4F2A, the 7.3-kb NotI-generated fragment from ptet. splicePL3-OSKMpA was blunt-ended and ligated with a EcoRV digested pBS246 plasmid (containing two loxP sites). The resulting pBS246.tetO-OSKMpA was digested with NotI generating a fragment of 7.6 kb that was ligated into the previously mentioned NotI-digested mCol.loxneo targeting vector. The resulting vector Col1a1 2lox 4F2A was digested for targeting of V19 ESCs as described above. (iii) To generate Col1a1 3F2A, first, a three-factor cDNA containing Oct4-T2A-Klf4-c-Myc was generated by PCR amplification of Oct4 using 5′ XbaI-EcoRI and SphI containing primers whose product was then TOPO cloned following manufacturer's instructions (pCR 2.1 TOPO; Invitrogen). The TOPOOct4 plasmid was then digested with XbaI and SphI and the 1.1 kb Oct4 cDNA was ligated to a similarly digested FUW-Ubi-4F2A ~10 kb fragment. The resulting FUW-Ubi-3F2A was digested with EcoRI to generate a ~4.0 kb fragment that was cloned into the ptet.splicePL3 vector as described above. A 6.3 kb fragment from ptet.splicePL3-tetO-3F2ApA was generated by NotI digestion and ligated into the mCol.loxneo targeting vector. The resulting 17-kb plasmid (containing Col1a1 3F2A) was linearized with PvuI restriction enzyme (25 µg), precipitated, resuspended in 400 µl HEPES and electroporated into V19 cells. Selection was the same as described above.
Mouse chimera and teratoma formation. Diploid blastocysts (94-98 h after hCG injection) were placed in a drop of Hepes-CZB medium under mineral oil. A flat-tip microinjection pipette with an internal diameter of 16 µm was used for iPSC injections. Each blastocyst received 8-10 iPSCs or ESCs. After injection, blastocysts were cultured in potassium simplex optimization medium (KSOM) and placed at 37 °C until transferred to recipient females. About 10 injected blastocysts were transferred to each uterine horn of 2.5 d post-coitum pseudo-pregnant B6D2F1 female. Pups were recovered at day 19.5 and fostered to lactating B6D2F1 mothers when necessary (Supplementary Table 4) . Teratoma formation was performed by depositing 2 × 10 6 cells under the flanks of recipient SCID mice. Tumors were isolated 3-6 weeks later for histological analysis. Mice were killed before tumor size exceeded 1.5 cm in diameter. All mouse experiments were approved by the Animal Care Committee at the Massachusetts Institute of Technology.
Somatic cell isolation and culture. For MEF isolation, chimeric embryos were isolated at E13.5, and the head and internal organs were removed. The remaining tissues were physically dissociated and incubated in trypsin at 37 °C for 20 min after which cells were resuspended in MEF medium. Twenty-four hours later, puromycin (2 µg ml −1 ) was added, and the cells were expanded for two passages before freezing or plating in doxycylinecontaining medium (2 µg ml −1 ) for reprogramming experiments. Somatic organs were isolated from 4-6-week-old transgenic mice. Epidermal keratinocytes and intestinal epithelium were isolated and grown as previously described 6 . For mesenchymal stem cells and pro-B cells whole marrow was isolated from the femur and tibia after removal of the condyles at the growth plate by flushing with a syringe and 30-gauge needle containing DMEM with 5% FBS (Hyclone; Thermo Fisher Scientific). CD19 + pro-B cells were isolated by MACS cell separation (Miltenyibiotec) following manufacturer's instructions. Purified B cell subsets were resuspended in IMDM with 15% FCS as well as IL-4, IL-7, SCF (10 ng ml −1 each; Peprotech), doxycyline (2 µg ml −1 ) and plated on OP9 bone marrow stromal cells (ATCC). Three days later the medium was changed to ESC medium plus doxycyline. Macrophage cells (CD11b + ) from freshly isolated spleen were isolated by MACS cell separation and plated by a similar protocol described for CD19 + pro-B cells. Mesenchymal stem cells were selected through differential plating on tissue culture plates (10 cm) for 72 h in α-MEM supplemented with 15% FBS. Once plates reached a full monolayer cells were split into 6-well dishes and cultured in the presence of doxycyline. For isolation of liver cells mice were first perfused with 50 ml HBSS buffer (without Ca 2+ and Mg 2+ ) then 50 ml HBSS (without Ca 2+ and Mg 2+ ) containing collagenase (type IV) (Sigma) (100 U ml −1 ). Liver was dissected away from surrounding tissues and dissociated in 10 ml DAG media (phenolred free DMEM Gibco and BSA 1g per 0.5 l) and filtered two times through a sterile 100 µM cell strainer. Liver cell preparations were centrifuged at 30g for 3 min at 4 °C and the cells were washed two times with DAG medium and then plated on γ-irradiated MEFs in ESC medium with doxycyline.
Reprogramming somatic cells. For 3F2A and 4F2A MEF reprogramming experiments colonies were initially observed around day 16 after doxycyline addition. Cells were initially seeded at ~25-50 cells mm −2 . Isolated liver and intestinal epithelium cells were typically divided into three 6-well plates containing γ-irradiated MEFs in ESC medium with doxycyline. For all other adult tissues reprogrammed in 4F2A mice, colonies were observed on day 12-20 after doxycyline addition. Manual picking and propagation of colonies was performed on days 22-35 by passaging onto γ-irradiated feeders. For 3F2A MEF
